ETODOLAC
Generic: ETODOLAC
Aurobindo Pharma LimitedManufacturer
ORALRoute
ETODOLACActive Substance
2026-07-15Original Approval
ETODOLAC is FDA application ANDA214872, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
367 reports
2
PAIN
354 reports
3
NAUSEA
292 reports
4
ARTHRALGIA
285 reports
5
FATIGUE
279 reports
6
HEADACHE
240 reports
7
DIARRHOEA
235 reports
8
DYSPNOEA
224 reports
9
DIZZINESS
208 reports
10
RASH
204 reports